?? On-Demand Webinar: Neurodegenerative Disease Biomarker Detection Tune in to hear Dr. Henrik Zetterberg, from University of Gothenburg, discuss his work discovering and validating blood-based biomarkers for CNS disorders, with a focus on Alzheimers Disease, using Alamar's #NULISA immunoassay platform for the detection of biomarkers in serum. ?? Watch now to hear the latest in neurodegenerative disease research: https://ow.ly/K6yJ50UeBUH #NeurodegenerativeDiseases #AlzheimersDisease #BiomarkerDetection
Alamar Biosciences, Inc.
生物技术研究
Fremont，California 14,311 位关注者
Powering Precision Proteomics with unrivaled sensitivity and simplicity
关于我们
Alamar Biosciences is powering precision proteomics with automated, high throughput solutions for ultra-high sensitivity protein analysis across a range of multiplex levels. Our proprietary NULISA? Chemistry utilizes a novel sequential capture and release method that significantly reduces background signal and increases the sensitivity and dynamic range compared with standard approaches and allows both qPCR and NGS readouts. The NULISAseq Inflammation Panel contains 200+ important markers related to immune and inflammatory diseases and will run on our ARGO? System. This innovative platform allows for a fully automated workflow with less than 30 minutes hands on time from sample to data.
- 网站
-
https://www.alamarbio.com
Alamar Biosciences, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Fremont，California
- 类型
- 私人持股
- 创立
- 2018
地点
-
主要
获取路线
47071 Bayside Pkwy
US，California，Fremont，94538
Alamar Biosciences, Inc.员工
动态
-
Welcome back to Pub Crawl! Today, we’re spotlighting groundbreaking research from Drs. Nicholas Asthon and Henrik Zetterberg from University of Gothenburg on biomarker discovery for Alzheimer's and other neurodegenerative diseases with #NULISA. ?? Pub Crawl #3:?Biomarker Discovery in Alzheimer’s and Neurodegenerative Diseases using Nucleic Acid-Linked Immuno-Sandwich Assay - bioRxiv & medRxiv ?? Crawl the pub: https://lnkd.in/gCbT2BW4 Stay tuned for more scientific highlights! Follow us to keep up with the series. #AlzheimersResearch #Biomarkers #Neurodegeneration #Proteomics
-
You don't have to take our word for it... "I really think this platform is a game-changer as it will allow to analyze all the AD-relevant biomarkers in one single assay, using only 15ul of sample with very low hands-on time, decreasing errors in sample handling." Dr. Carlos Cruchaga. Access the recent pub: https://lnkd.in/gKrDDE_E #Alzheimers #NULISA #ProteinBiomarkers #immunoassay
A lot of novel biomarkers for #Alzheimers have been reported recently, including ptau217, ptau181, ptau231, Aβ40,42, NFL, NRGN, GFAP, TREM2..... but until recently there was not a single platform that can measure all of them. In a recent study we analyzed the performance of NULISA (Alamar Biosciences, Inc.) platform in CSF and plasma samples from Alzheimer cases and controls. We found very high correlation (r>0.9) of the most relevant biomarkers when comparing with well-validated assays. Ptau217 showed very good performance in both CSF and plasma showing comparable AUC against amyloid PET, than other assays. All the other assays also showed very good performance. I really think this platform is a game-changer as it will allow to analyze all the AD-relevant biomarkers in one single assay, using only 15ul of sample with very low hands-on time, decreasing errors in sample handling. We have a couple of large scale studies studies (ISVARAD; https://www.isavrad.org/; DIAN: https://dian.wustl.edu/ or AABC: https://lnkd.in/gzuKb3Wp) we plan to implement this platform. Full manuscript: https://lnkd.in/gdbuZhUP
-
-
?? Tune in for an exciting podcast on Large-Scale Proteomics with Dr. Chris Whelan, Director of Neuroscience, Johnson & Johnson Innovative Medicine. Dive into the groundbreaking work on the Pharma Proteomics Project and how large-scale proteomics, powered by Alamar’s cutting-edge #NULISA immunoassay platform, is revolutionizing the future of healthcare. Listen now ?? https://ow.ly/k6VK50UciRS #Proteomics #BioPharma #Immunoassay
-
-
Congratulations to Drs. Laura Ibá?ez Lladó and Carlos Cruchaga for their recent publication just out in Alzheimer's Association?'s Alzheimer's & Dementia journal. The study provides a benchmark for our #NULISA #proteomics technology and it's use in AD and Dementia research! https://lnkd.in/gKrDDE_E
-
Welcome back to Pub Crawl, where we break down the latest in scientific research! Today, we explore a comprehensive survey of circulating proteomics by HUPO’s Human Plasma Proteome (HPP) Project from Dr. Jochen Schwenk from the Science for Life Laboratory, Department of Protein Science, KTH Royal Institute of Technology. ?? Pub Crawl #2: Unveiling the Circulating Proteome The Circulating Proteome─Technological Developments, Current Challenges, and Future Trends – Journal of Proteome Research ?? Crawl the pub: https://lnkd.in/gnccb9kV Stay tuned for more insights from transformative publications. Follow us for a frequent dose of innovation! #Proteomics #BiomedicalResearch #HPPP #Innovation
-
A HUGE ALAMAR WELCOME to our newest #ARGOnauts: Tessa Eller, Alex Schwefel, Kristen Russ, Riley Crump and Jeffrey Dage from Indiana University School of Medicine! Looking forward to our continued partnership and the brilliant research to come! #NULISA #proteomics #immunosassays #neurodegeneration
-
-
Unlock Unprecedented Sensitivity in Proteomics with The #NULISA Platform – Revolutionizing Biomarker Detection at Attomolar Levels with its: ? Best-in-class attomolar sensitivity ? Broad dynamic range ? Multiplexed ? Fully automated workflow Discover why leading experts are using NULISA technology to enable the earliest detection of disease and push the boundaries of protein research ?? https://ow.ly/3wXs50U9ylY #Proteomics #BiomarkerDiscovery #PrecisionMedicine
-
Kicking off Alamar’s Pub Crawl, a new series where we dive into the latest groundbreaking research and distill the key insights for you. Each crawl highlights the cutting-edge science shaping our world—follow us to stay in the loop! Pub Crawl No.1: Revolutionizing Blood Proteomics with #NULISA? ?? Nature Communications - "NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing"?? ?? Crawl the pub: https://lnkd.in/gRYsCMMg Follow us for more "pub crawls" through groundbreaking science! #Proteomics #PrecisionMedicine #ResearchInnovation #NULISA
-
We are proud to announce that Alamar Biosciences has entered into a strategic collaboration with The Michael J. Fox Foundation for Parkinson's Research, (MJFF), to accelerate the discovery of biomarkers and deepen our understanding of Parkinson’s disease. This partnership brings together two powerful forces in Parkinson’s research: MJFF’s world-class PPMI dataset and Alamar’s #NULISA technology. By joining forces, we are taking significant steps toward uncovering new insights and advancing precision medicine for Parkinson’s disease. ?? Read more about this groundbreaking partnership: https://lnkd.in/gwzyjnsN #ParkinsonsResearch #NULISA #Proteomics #MJFF #NeurodegenerativeDiseases
-